CRNX

Crinetics Pharmaceuticals Inc

$84.70
0.26 (0.31%) Today
Compare CRNX
Market Cap
$8.98B+175.7%
Revenue (TTM)
$42.27M+2928.4%
Net Income (TTM)
$-533,973,384
EPS (TTM)
-5.05
Shares Out
105.84M
Open
$84.70
Previous Close
$84.44
Day Range
$84.37 – $84.70
52-Week Range
$28.73 – $84.71
Beta
0.02
Earnings Date
Nov 4, 2026
Volume
2.25M
Avg Volume
3.01M
Analyst Rating
Hold
Exchange
NASDAQ NMS - GLOBAL MARKET

About CRNX

Crinetics Pharmaceuticals is a global pharmaceutical company known for developing drugs for the treatment of endocrine-related diseases. It was founded by Scott Struthers, Frank Zhu, Ana Kusnetzow, and Stephen F. Betz in 2008 and is headquartered in San Diego, California. It went public on NASDAQ in 2018.

Related

CORTvs
ELANvs
AXSMvs
BLTEvs
LQDAvs

News

N/A
Israeli strike kills seven in south Lebanon, state news reports​ - Reuters
Reuters · 50m ago
N/A
Taliban mark five years in power as aid groups warn of crisis - Reuters
Reuters · 1h ago
Inflation moderated as Intel and Nvidia fueled the AI trade in last week's market
CNBC · 1h ago
Marijuana reform is emerging as a midterm elections issue on both sides of the aisle
CNBC · 2h ago
N/A
A $50 million hostage ransom funded al Qaeda's Mali offensive, UN says - Reuters
Reuters · 16h ago